CytomX Therapeutics (CTMX) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.04
0.11
0.27

Details

Expected EPS
0.124754
Actual EPS
0.27
Surprise EPS
0.15
Surprise Percent
+116.43%

Description

CytomX Therapeutics (CTMX) has reported earnings of 0.27 per share for Q2 2025.

0 Comments

Share your thoughts